The Zhitong Finance App learned that on April 22, under the guidance of the Beijing Haidian District Health Commission and Zhongguancun Science City, Eagle Eye Technology-B (02251) and 48 primary medical institutions in Haidian District jointly launched the construction of an “Artificial Intelligence Eye Diagnosis and Treatment Collaboration Platform”. This platform is not only the first example of privatization deployment in a medical consortium region in the country, but its integrated AI technology will greatly enhance general collaboration capabilities.

As the first stock of AI healthcare, Eagle Hitomi Technology has always been committed to deeply integrating artificial intelligence technology with healthcare and promoting the transformation of scientific and technological achievements. The construction and promotion of the “Artificial Intelligence Eye Diagnosis and Treatment Collaboration Platform” is an iconic advance in AI medical technology. It aims to create a new model of primary care services through advanced artificial intelligence technology to provide more accurate and efficient disease diagnosis, treatment and risk management for the general public.

According to reports, the “Artificial Intelligence Eye Diagnosis and Treatment Collaboration Platform” has four main characteristics: first, algorithm compression helps efficient migration, that is, “12 disease modules and 12 types of lesion segmentation modules to the cloud”; second, the government cloud deploys stress test scripts to ensure accurate and stable diagnosis results and adapts to dynamic expansion plans and disaster recovery measures; and fourth, the security system is properly connected and operated smoothly in the community.

Up to now, the “Artificial Intelligence Eye Diagnosis and Treatment Collaboration Platform” has screened 20125 people in Haidian hospitals and communities; completed 21 project communication and equipment installations; completed 6,389 people screened 8,678 in the community; and 40% of people were referred for treatment with 34 major positives.

Regarding the launch of the “Artificial Intelligence Eye Diagnosis and Treatment Collaboration Platform”, Lin Hang, deputy district governor of the Beijing Haidian District People's Government, believes that it is of great significance in improving the accuracy of screening for major diseases and chronic diseases, relieving the pressure on primary doctors to diagnose and treat long-term diseases, promoting the implementation of a hierarchical diagnosis and treatment system, and constructing a new model of online and offline medical services. He pointed out that the platform construction launched today is not only about Eagle Hitomi Technology, but also hopes that in the future, more innovative medical technology companies will enter, expand the implementation of scenarios, and strengthen applications at the grassroots level, so that the significance of early screening and early diagnosis can be implemented.